Protein Regulatory Mechanism
Protein modifications by formaldehyde treatment and histological processing have frustrated attempts to use FFPE tissues for proteomic analyses due to the difficulty in extracting representative proteins. Ubiquitin and Ubiquitin-like modifications are some of the examples. This limitation has restricted studies of diseases that evolve slowly or for those where the time between treatment and recurrence is long, such as prostate and breast cancer. The Multivesicular body and endocytosis are being studied for investigating these diseases. Coupling the medical history and pathology information from FFPE tissues with proteomic investigations would produce a wealth of practical information on important human diseases and will also unveil the Mechanisms of bacterial pathogenesis. Major change in the structure can be caused by Regulatory thiol modifications.
Relevant Conferences: 6th International Conference & Expo on Proteomics, March 29-30, 2016 Atlanta, USA; World Congress on Amino Acids and Proteins, December 08-09, 2016 Baltimore, USA; 2nd International Conference on Genetic and Protein Engineering, November 14-16, 2016 Atlanta, USA; International Conference on Biochemistry, October 13-15, 2016 Kuala Lumpur, Malaysia; : 3rd World Congress on Pharmacology, August 08-10, 2016 Birmingham, UK; Keystone Symposia on Ubiquitin Signaling (X3), March 13—17, 2016 Whistler, British Columbia, Canada; Gordon Research Conference on Intrinsically Disordered Proteins, June 26 - July 1, 2016 Les Diablerets, Switzerland; BITS 9th Annual World Protein & Peptide Conference, April 25-28, 2016; International conference center,Dalian,China; Keystone Symposia on Neurological Disorders of Intracellular Trafficking (A7), January 31—February 4, 2016 Colorado, USA; ; XXII International Roundtable on Nucleosides Nucleotides and Nucleic Acids,
 on July 18-22, 2016 at Institut Pasteur – Paris, France.
- Ubiquitin and Ubiquitin-like modifications
- The Multivesicular body and endocytosis
- Regulatory thiol modifications
- Mechanisms of bacterial pathogenesis
- Proteomics of posttranslational modification
Related Conference of Protein Regulatory Mechanism
Translational Neuroimmunology From Mechanisms to Therapeutics
FASEB 3rd International Conference on Retinoids
Cell Gene Therapy Congress 2015
The Biology of Calpains in Health and Disease
Cell Signaling in Cancer From Mechanisms to Therapy
Microbial Glycobiology
Protein Folding in the Cell
ICBE International Conference Biomolecular Engineering
Matricellular Proteins in Development Health and Disease
Protein Kinase Signaling Network Regulation
Protein Regulatory Mechanism Conference Speakers
Recommended Sessions
Related Journals
Are you interested in
- 3D Structure Determination - Structural Biology-2026 (France)
- Advanced Drug Delivery Systems for Metabolic Therapy - DRUG CHEMISTRY CONF 2026 (France)
- Advanced Techniques in Structural Biology - Structural Biology-2026 (France)
- AI & Computational Structural Biology - Structural Biology-2026 (France)
- Biochemistry and Biophysics - Structural Biology-2026 (France)
- Biomarker-Guided Drug Development - DRUG CHEMISTRY CONF 2026 (France)
- Chemical Biology Tools in Metabolic Research - DRUG CHEMISTRY CONF 2026 (France)
- Computational Approach in Structural Biology - Structural Biology-2026 (France)
- Computational Drug Design and Molecular Modeling - DRUG CHEMISTRY CONF 2026 (France)
- Drug Designing and Biomarkers - Structural Biology-2026 (France)
- Drug Resistance and Therapeutic Durability - DRUG CHEMISTRY CONF 2026 (France)
- Enzyme Modulation Approaches in Antidiabetic Drug Design - DRUG CHEMISTRY CONF 2026 (France)
- Epigenetic Regulation and Small-Molecule Therapeutics - DRUG CHEMISTRY CONF 2026 (France)
- Future Directions in Drug Chemistry for Diabetes Management - DRUG CHEMISTRY CONF 2026 (France)
- Hybrid Approaches for Structure Prediction - Structural Biology-2026 (France)
- Lipid Chemistry and Metabolic Regulation - DRUG CHEMISTRY CONF 2026 (France)
- Medicinal Chemistry Strategies for Metabolic Disorders - DRUG CHEMISTRY CONF 2026 (France)
- Membrane Proteins and Receptors - Structural Biology-2026 (France)
- Molecular Modelling and Dynamics - Structural Biology-2026 (France)
- Natural Product Chemistry in Diabetes Drug Discovery - DRUG CHEMISTRY CONF 2026 (France)
- Oxidative Stress Modulation through Drug Chemistry - DRUG CHEMISTRY CONF 2026 (France)
- Peptide and Protein-Based Drug Chemistry - DRUG CHEMISTRY CONF 2026 (France)
- Pharmacokinetics and Drug Metabolism Studies - DRUG CHEMISTRY CONF 2026 (France)
- Prodrug Design and Chemical Activation Strategies - DRUG CHEMISTRY CONF 2026 (France)
- Proteomics and Genomics - Structural Biology-2026 (France)
- Regulatory Chemistry and Drug Safety Assessment - DRUG CHEMISTRY CONF 2026 (France)
- Structural Bioinformatics and Computational Biology - Structural Biology-2026 (France)
- Structural Biology in Cancer Research - Structural Biology-2026 (France)
- Structural Virology - Structural Biology-2026 (France)
- Structural Virology and Infectious Diseases - Structural Biology-2026 (France)
- Structure-Based Drug Discovery - Structural Biology-2026 (France)
- Structure-Based Solutions to Global Health Challenges - Structural Biology-2026 (France)
- Structure-Function Relationships - Structural Biology-2026 (France)
- Structure–Activity Relationship Studies in Drug Chemistry - DRUG CHEMISTRY CONF 2026 (France)
- Synthetic Chemistry Innovations in Drug Development - DRUG CHEMISTRY CONF 2026 (France)
- Targeting Pancreatic Function through Drug Chemistry - DRUG CHEMISTRY CONF 2026 (France)
- The Structural Basis of Disease - Structural Biology-2026 (France)
- Translational Drug Chemistry from Bench to Clinic - DRUG CHEMISTRY CONF 2026 (France)
